NUGS.US Cannabis Strategic Ventures
- Market cap
- USD 1.69M
- P/E
- -
- P/B
- 113.91x
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Sep 2023.
Is NUGS.US undervalued?
Graham numberThe Graham number of Cannabis Strategic Ventures cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Cannabis Strategic Ventures fundamental analysis
No fundamental analysis for Cannabis Strategic Ventures yet.
Cannabis Strategic Ventures stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Cannabis Strategic Ventures
Cannabis Strategic Ventures engages in the cultivation of marijuana products in the United States. It incubates, develops, and partners within the cannabis and ancillary sectors. The company is based in Los Angeles, California.
Full company profileCannabis Strategic Ventures financial statements
2023 annualized: Fiscal year 2023 is not finished. Income statement and cash flow are annualized from 2 quarters up to Sep 30, 2023, the balance sheet is the latest quarter. Figures change when the annual report is published.
Cannabis Strategic Ventures annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2006 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 11.2K | 372K | 150K | 0.00 | 0.00 | 345K | 702K | 2.37M | 14.6M | 9.85M | - |
| Gross Profit | -644.00 | 74.1K | 27.2K | 0.00 | 0.00 | 249K | 21.1K | 477K | 2.78M | 922K | - |
| Operating Income | -762K | 49.2K | 11.8K | -97.2K | -18.2K | -4.45M | -21.1M | -8.58M | -5.30M | -7.22M | - |
| EBITDA | -1.85M | 49.2K | 11.8K | -1.89M | 86.0K | -5.58M | -21.1M | -8.91M | -5.04M | -5.70M | - |
| Net Income | -6.68M | 49.2K | 11.8K | -73.8K | 86.0K | -8.41M | -21.4M | -9.06M | -5.64M | -8.60M | - |
| EPS | -2.87 | - | 0.00 | 0.00 | 0.00 | -0.04 | -0.08 | -0.04 | -0.02 | -0.03 | - |
| Balance Sheet | |||||||||||
| Total Assets | - | 21.0K | 2.82K | 67.00 | 67.00 | 12.4M | 2.84M | 17.7M | 16.0M | 11.2M | 10.8M |
| Total Liabilities | - | 199K | 58.8K | 133K | 41.1K | 1.74M | 2.41M | 23.5M | 23.9M | 20.0M | 19.5M |
| Shareholders' Equity | - | -178K | -56.0K | -133K | -41.0K | 10.7M | 423K | -5.75M | -7.93M | -8.86M | -8.68M |
| Cash & Short-term Investments | - | 4.34K | 1.22K | 67.00 | 67.00 | 354K | 74.7K | 488K | 403K | 25.2K | 23.9K |
| Total Debt | - | 178K | 39.0K | - | - | - | 625K | 21.5M | 21.7M | 13.9M | 13.6M |
| Cash Flow | |||||||||||
| Operating Cash Flow | - | 38.1K | 25.7K | -1.14K | -17.0K | -524K | -2.53M | -7.64M | -4.09M | -1.43M | - |
| Capital Expenditure | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 34.2K | 3.40M | 811K | 4.00 | 10.00 |
| Free Cash Flow | - | 38.1K | 25.7K | -1.14K | -17.0K | -524K | -2.57M | -11.0M | -4.90M | -1.43M | - |
| Ratios | |||||||||||
| ROE | - | - | - | - | - | -78.6% | -5,071.1% | - | - | - | - |
| ROA | - | 234.3% | 418.3% | -110,116.4% | 128,313.4% | -67.6% | -755.6% | -51.0% | -35.2% | -77.0% | - |
| Net Profit Margin | -59,771.0% | 13.2% | 7.9% | - | - | -2,439.8% | -3,053.2% | -382.6% | -38.6% | -87.3% | - |
| Debt to Equity | - | - | - | - | - | - | 1.48x | - | - | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Cannabis Strategic Ventures dividends
Cannabis Strategic Ventures has not paid dividends in the last 9 fiscal years.
Last stock split: 1:25 on Apr 29, 2015.
Who owns Cannabis Strategic Ventures
Ownership data of Cannabis Strategic Ventures is not available yet.
Cannabis Strategic Ventures company profile
- Company name
- Cannabis Strategic Ventures
- Ticker
- NUGS.US
- Exchange
- USA Stocks
- Sector
- Financial Services
- Industry
- Pharmaceuticals
- Employees
- 30
- Fiscal year end
- March
- Address
- 833 South Spring, Los Angeles, CA, United States, 90014
- Phone
- 310-359-6860
- Website
- cannabisstrategic.com
About Cannabis Strategic Ventures
Cannabis Strategic Ventures engages in the cultivation of marijuana products in the United States. It incubates, develops, and partners within the cannabis and ancillary sectors. The company is based in Los Angeles, California.
Cannabis Strategic Ventures management
3- Richard C. HawkinsChief Executive Officer
- Paul HutchinPresident
- Ms. Arlene GuzmanVice President of Operations